Proteomic identification of a stress protein, mortalin/mthsp70/GRP75: relevance to Parkinson disease.
about
Proteome analysis of human substantia nigra in Parkinson's diseaseBiochemical premotor biomarkers for Parkinson's diseaseCerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation.Evidence for a common biological pathway linking three Parkinson's disease-causing genes: parkin, PINK1 and DJ-1Human mitochondrial Hsp70 (mortalin): shedding light on ATPase activity, interaction with adenosine nucleotides, solution structure and domain organizationHeat shock proteins: cellular and molecular mechanisms in the central nervous system.Heat shock proteins in neurodegenerative disorders and agingComputational deconvolution of genome wide expression data from Parkinson's and Huntington's disease brain tissues using population-specific expression analysis.The role of biomarkers and imaging in Parkinson's disease.Identification of novel proteins affected by rotenone in mitochondria of dopaminergic cellsToward defining the anatomo-proteomic puzzle of the human brain: An integrative analysis.Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression.Glycoproteomics in neurodegenerative diseases.Proteomics analysis of MPP+-induced apoptosis in SH-SY5Y cells.The proteome of human brain after ischemic stroke.Region-specific protein abundance changes in the brain of MPTP-induced Parkinson's disease mouse modelCloning, characterization, and functional studies of a human 40-kDa catecholamine-regulated protein: implications in central nervous system disorders.Neuroproteomics approaches to decipher neuronal regeneration and degeneration.Biomarkers for cognitive impairment in Parkinson disease.Gene expression profiling and association with prion-related lesions in the medulla oblongata of symptomatic natural scrapie animals.Kinetic and structural characterization of human mortalinUsing 'omics' to define pathogenesis and biomarkers of Parkinson's disease.Biomarker discovery in neurodegenerative diseases: a proteomic approach.Water extract of ashwagandha leaves limits proliferation and migration, and induces differentiation in glioma cellsAstrocytic dynamin-like protein 1 regulates neuronal protection against excitotoxicity in Parkinson disease.Quantitative proteomic analysis of oligodendrogliomas with and without 1p/19q deletionDown-regulation of mortalin exacerbates Aβ-mediated mitochondrial fragmentation and dysfunction.Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative diseaseThe Broad Impact of TOM40 on Neurodegenerative Diseases in AgingMolecular chaperones in Parkinson's disease--present and futureDissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis.The use of MALDI-MSI in the investigation of psychiatric and neurodegenerative disorders: A review.Enhanced J-protein interaction and compromised protein stability of mtHsp70 variants lead to mitochondrial dysfunction in Parkinson's diseaseSwedish Alzheimer mutation induces mitochondrial dysfunction mediated by HSP60 mislocalization of amyloid precursor protein (APP) and beta-amyloid.Mortalin is Expressed by Astrocytes and Decreased in the Midbrain of Parkinson's Disease Patients.Quantitative proteomic analysis for radiation-induced cell cycle suspension in 92-1 melanoma cell lineAlpha-synuclein and Parkinson's disease: a proteomic view.Mitochondrial protein targets of thiol-reactive electrophilesProteomics of human neurodegenerative diseasesProteomic analysis of rat brain mitochondria following exposure to dopamine quinone: implications for Parkinson disease.
P2860
Q21245637-385558F5-C0BE-4DDB-BDE0-4311CFBA610EQ27008467-7471E5F6-9212-4E83-9E16-1ED6849A4BBDQ27311994-DFD4C44F-0C6D-48EE-B936-BD82D637FC1FQ28258696-5DAE087B-3015-4564-B55C-E14A60F2D071Q28543073-BE69F620-DD1C-40C2-A745-F5C05629E11EQ30392284-611501E7-14D9-414D-ACB3-09AD02FCA9C2Q30414556-22966AC0-E0CB-4164-9C4F-3C01C650E520Q30885974-0D2ECB5B-747C-45C2-9EE6-E6C9885D2055Q31041660-C8B8D6E3-ED81-4894-B76A-02DFBF0ECBD9Q33294492-CE3F2ECB-1172-4763-A8EB-F9F0AEA34457Q33359479-7EBC8F91-046F-4C2D-915C-EF591EE06A7AQ33460911-0493E4C1-CE7F-455A-B47C-70BA7CEE0F50Q33563387-4762EC1A-35F2-4632-AB57-2859926CF841Q33610182-C68B14FA-2CEA-4ABE-89D0-3A1012B5EFEBQ33715975-31F7B378-2C07-4CC9-9A55-56D4579EBCD3Q33810589-4894EFF7-C3D3-40B0-9159-A7F3D6586206Q33838788-2AA32FD9-4BF6-4E10-83BE-84FED6AC7E15Q33855014-5C8C4441-0C67-47D8-93C1-93202A6F1FFDQ33896664-10E4C464-8124-45A3-9879-0BCCA139D5C9Q33918266-E229306F-C840-4F1E-B2F2-D8B9652B6DAAQ33919575-E875D7BC-7D59-4535-9EF0-9DA4555E6D6EQ34032608-DAA6D370-E17E-49D7-8F9D-31C51565356EQ34125681-4A9738BA-C078-41C6-A1EF-7DF550B7887AQ34987033-944B5226-7251-400A-9EBE-AD08435AC4B1Q35008510-098A07D7-5EC9-465A-BE94-46A5C2D6DFB6Q35058206-B107C697-F28D-43AD-B505-B213B6D071F2Q35063586-CAC5AC36-2564-4562-AE2F-5478C7A69B91Q35125001-91A3877A-93CB-46EC-9C72-07308453AE70Q35137172-457626EF-A6D3-4A0B-B8C9-5761F6F568B3Q35688796-BDC6295F-8F2F-439F-A209-D4AB827D9D3FQ35819806-9A483482-AD8E-4B9F-94F2-6FE0FA1D5250Q36052708-40C13F7D-C365-482E-9BB1-01338DB064E7Q36083113-5E19D0CC-5F90-45DA-B1CB-75D1EBC19FAFQ36216352-E79E83DA-6C80-4BD5-B52C-0C3C8B085134Q36366299-DD2CC45F-5DDE-4310-A69E-4E79EA2A95E2Q37006991-F9C44F5A-DD98-46F3-89B3-EF2B6470608CQ37157838-799E3B85-5DCB-4935-93F1-6A40BF07716EQ37247126-623C992D-9C18-4704-8E35-59C06250D283Q37260477-866B38EC-CABA-43A6-9023-1CA29A33F482Q37269603-8F6E1B6F-3CD6-450A-ADCB-9790ACD2A726
P2860
Proteomic identification of a stress protein, mortalin/mthsp70/GRP75: relevance to Parkinson disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Proteomic identification of a ...... elevance to Parkinson disease.
@en
Proteomic identification of a ...... elevance to Parkinson disease.
@nl
type
label
Proteomic identification of a ...... elevance to Parkinson disease.
@en
Proteomic identification of a ...... elevance to Parkinson disease.
@nl
prefLabel
Proteomic identification of a ...... elevance to Parkinson disease.
@en
Proteomic identification of a ...... elevance to Parkinson disease.
@nl
P2093
P1476
Proteomic identification of a ...... relevance to Parkinson disease
@en
P2093
Catherine Pan
Christine Hulette
Jing Zhang
Jinghua Jin
Terry Zhang
P304
P356
10.1074/MCP.M500382-MCP200
P50
P577
2006-03-24T00:00:00Z